Ohr Pharmaceutical Announces Efficacy Results from the MAKO Study in Wet-AMD
05 janv. 2018 06h00 HE
|
Ohr Pharmaceutical, Inc.
NEW YORK, Jan. 05, 2018 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (NASDAQ:OHRP), a clinical-stage pharmaceutical company developing novel therapies for ophthalmic diseases, today reported topline...
Ohr Pharmaceutical Reports Fiscal Year 2017 Financial Results
15 déc. 2017 07h00 HE
|
Ohr Pharmaceutical, Inc.
Management to Host a Conference Call and Webcast at 8:30 a.m. Eastern Time Today NEW YORK, Dec. 15, 2017 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (Nasdaq:OHRP), a clinical-stage pharmaceutical...
Ohr Pharmaceutical to Announce Fiscal Fourth Quarter & Year End 2017 Results on Friday, December 15
12 déc. 2017 08h00 HE
|
Ohr Pharmaceutical, Inc.
NEW YORK, Dec. 12, 2017 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (Nasdaq:OHRP), a clinical-stage pharmaceutical company developing novel therapies for ophthalmic diseases, today announced that...
Ohr Pharmaceutical to Present at the Dawson James 3rd Annual Small Cap Growth Conference
11 oct. 2017 08h00 HE
|
Ohr Pharmaceutical, Inc.
NEW YORK, Oct. 11, 2017 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (Nasdaq:OHRP), a clinical-stage pharmaceutical company developing novel therapies for ophthalmic diseases, today announced that...
Ohr Pharmaceutical Announces Fiscal Third Quarter 2017 Earnings
08 août 2017 16h01 HE
|
Ohr Pharmaceutical, Inc.
NEW YORK, Aug. 08, 2017 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (NASDAQ:OHRP), a clinical-stage pharmaceutical company developing novel therapies for ophthalmic diseases, today reported...
Ohr Pharmaceutical to Announce Fiscal Third Quarter 2017 Results on August 8
31 juil. 2017 08h00 HE
|
Ohr Pharmaceutical, Inc.
NEW YORK, July 31, 2017 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (Nasdaq:OHRP), a clinical-stage pharmaceutical company developing novel therapies for ophthalmic diseases, today announced that...
Ohr Pharmaceutical to Present at the 2017 Marcum Microcap Conference
12 juin 2017 08h00 HE
|
Ohr Pharmaceutical, Inc.
NEW YORK, June 12, 2017 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (Nasdaq:OHRP), a clinical-stage pharmaceutical company developing novel therapies for ophthalmic diseases, today announced that...
Ohr Pharmaceutical Announces Appointment of Hon. Mike Ferguson as Chairman of the Board of Directors
11 mai 2017 16h15 HE
|
Ohr Pharmaceutical, Inc.
NEW YORK, May 11, 2017 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (Nasdaq:OHRP), a clinical-stage pharmaceutical company developing novel therapies for ophthalmic diseases, today announced the...
Ohr Pharmaceutical Announces Fiscal Second Quarter 2017 Earnings
11 mai 2017 16h01 HE
|
Ohr Pharmaceutical, Inc.
NEW YORK, May 11, 2017 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (NASDAQ:OHRP), a clinical-stage pharmaceutical company developing novel therapies for ophthalmic diseases, today reported results...
Ohr Pharmaceutical to Announce Fiscal Second Quarter 2017 Results on May 11
09 mai 2017 08h00 HE
|
Ohr Pharmaceutical, Inc.
NEW YORK, May 09, 2017 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (NASDAQ:OHRP), a clinical-stage pharmaceutical company developing novel therapies for ophthalmic diseases, today announced that it...